Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Resistance to activated protein C: A common inherited cause of venous thrombosis

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Gillespie, D. L.
  • Carringion, L. R.
  • Griffin, John
  • Alving, B. M.

publication date

  • March 1996

journal

  • Annals of Vascular Surgery  Journal

abstract

  • Resistance to activated protein C (RAPC) is a newly recognized hypercoagulable state that was first described in 1993. It has become apparent that RAPC is even more common than deficiencies in protein C, protein S, or antithrombin III (AT-III) and affects an estimated 5% of the general population. The majority of patients with RAPC have an abnormality in factor V (Arg506Gln), which renders factor Va resistant to degradation by activated protein C. Studies in 75 patients referred to the Hematology Laboratory at Walter Reed Army Institute of Research (WRAIR) over a 14-month period for evaluation of venous thromboembolism were reviewed to determine the percentage of those with RAPC. Of the 75 patients in the study, one was deficient in protein S, one was deficient in protein C, and none was deficient in AT-III. In contrast, 27 (36%) patients tested positive for RAPC. Blood was available for DNA analysis in 15 patients with RAPC. Of these 15 patients, nine (60%) tested positive for the Arg506Gln mutation in factor V. Six other patients with RAPC did not have the factor V mutation. Additional risk factors for thrombosis were immobility, obesity, use of oral contraceptives, and pregnancy. The majority of patients had deep venous thrombosis of the lower extremities; 71% had a recurrence if not placed on chronic anticoagulation therapy. Thus RAPC is a significant risk factor for venous thrombosis. Evaluation for inherited hypercoagulable states should include testing for this newly described condition.

subject areas

  • Adolescent
  • Adult
  • Anticoagulants
  • Antithrombin III
  • Arginine
  • Contraceptives, Oral
  • DNA
  • Drug Resistance
  • Factor V
  • Female
  • Glutamine
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Obesity
  • Pregnancy
  • Protein C
  • Protein C Deficiency
  • Protein S Deficiency
  • Recurrence
  • Risk Factors
  • Thromboembolism
  • Thrombophlebitis
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0890-5096

Digital Object Identifier (DOI)

  • 10.1007/bf02000762

PubMed ID

  • 8733870
scroll to property group menus

Additional Document Info

start page

  • 174

end page

  • 177

volume

  • 10

issue

  • 2

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support